Suchergebnisse - "Wong, Anthony C"

PubPharm (34)

1

Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer

enthalten in: European urology | 2023

von Herlemann, A. | Cowan, J. | Washington, S. | +4

2

Outcomes of salvage high dose-rate brachytherapy with or without pelvic external beam radiotherapy in patients with palpable local recurrence of prostate cancer after radical prostatectomy

enthalten in: Brachytherapy | 2023

von Ni, L. | Chen, K. | Phuong, C. | +4

3

Painless Rectal Bleeding in a Patient With Prostate Cancer

enthalten in: Gastroenterology | 2022

von Medina, S. | Wong, A. | El-Nachef, N.

4

Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer : Results From a Phase 2 Trial

enthalten in: Advances in radiation oncology | 2022

von Shee, K. | de la Calle, C. | Chang, A. | +5

5

Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost

enthalten in: Radiation oncology (London, England) | 2022

von Phuong, C. | Chan, J. | Ni, L. | +5

6

Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost

enthalten in: Radiation oncology | 2022

von Phuong, C. | Chan, J. | Ni, L. | +5

7

Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost

enthalten in: Radiation oncology | 2022

von Phuong, C. | Chan, J. | Ni, L. | +5

8

Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer

enthalten in: Investigative and clinical urology | 2022

von Greenland, N. | Cooperberg, M. | Wong, A. | +4

9

Salvage High-Dose-Rate Brachytherapy for Recurrent Prostate Cancer After Definitive Radiation

enthalten in: Practical radiation oncology | 2021

von Wu, S. | Wong, A. | Shinohara, K. | +4

10

TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor

enthalten in: Journal for immunotherapy of cancer | 2021

von de Kouchkovsky, I. | Zhang, L. | Philip, E. | +18

ErratumIn: J Immunother Cancer. 2021 Sep;9(9):. - PMID 34489336